Global Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) Market, By Symptoms (External Ophthalmoplegia, Gastrointestinal Dysmotility, Cachexia, Peripheral Neuropathy, Leukoencephalopathy), Treatment (Drug Therapies, Occupational and Physical Therapy), Route of Administration (Oral, Injection), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.